Get all your news in one place.

100’s of premium titles.
One app.

Start reading

Get all your news in one place.

100’s of premium titles. One news app.

Start reading

The Latest Breaking News from Intellia Therapeutics

Stocks With Rising Relative Price Strength: Intellia Therapeutics

Intellia Therapeutics sees its Relative Strength Rating hit the 80-plus level.

Investors Business Daily

Stocks With Rising Relative Strength: Intellia Therapeutics

Intellia Therapeutics shows rising price performance, earning an upgrade to its IBD Relative Strength Rating

Investors Business Daily

Goldman Spotlights These 3 Stocks in Its Bullish S&P 500 Outlook

Goldman Sachs raised its year-end S&P 500 forecast and identified three stocks that are poised to outperform in the second half of 2025: KSS, NTLA, and GOGO.

MarketBeat

From analysis to the latest developments in health,
read the most diverse news in one place.

Intellia Therapeutics Sees Relative Strength Rating Climb To 73

Intellia Therapeutics shows rising price performance, earning an upgrade to its IBD Relative Strength Rating

Investors Business Daily

2 Hot Growth Stocks Poised for Gains of Up to 370%, According to Wall Street

These biotech companies’ strategic advancements are setting them up for long-term success.

Barchart

This Cathie Wood Stock Can Soar 221%, Says Wall Street

Promising clinical trial results have analysts optimistic about the company’s future.

Barchart

3 Cathie Wood Biotech Stocks That Analysts Expect to Double

This article delves into three biotech stocks held in Cathie Wood's ARKK ETF that analysts expect to double in value. Investors looking to add exposure to promising biotech opportunities, with a preference for Wood's disruptive approach to investing, may find these stocks particularly compelling.

Barchart

Read news from The Economist, FT, and more,
with one subscription

'This is the future': ACT trials gene-editing to treat heart patient

The technology is literally 'cutting' edge.

The Canberra Times

Analysts Agree These 8 Cathie Wood Stock Picks Will Soar In 2024

Cathie Wood's ARK Innovation ETF isn't afraid to go against Wall Street and the S&P 500. But in some cases, the consensus agrees with the famed ETF manager.

Investors Business Daily

Cathie Wood's ARK Innovation Just Had Its Best Week Ever Thanks To Roku, These Huge Winners

Cathie Wood's flagship Ark Innovation ETF ARKK just had its best week ever thanks to Roku, DraftKings, Palantir and other huge winners on big news.

Investors Business Daily

CRISPR Stock Intellia Therapeutics Thinks It Has The Cure To A Swelling Disorder

NTLA stock rose Monday after Intellia said its CRISPR-based gene-editing drug almost totally eliminated attacks in a swelling disease.

Investors Business Daily

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

SP Global Market Intelligence

Palantir Technologies

237 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.